Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Pharm Dev Technol. 2020 Feb 12;25(5):625–639. doi: 10.1080/10837450.2020.1725893

Figure 13.

Figure 13.

Comparison of oral pharmacokinetic parameters (Cmax and AUClast) of ELQ-300 in male Sprague-Dawley rats. SDD: Spray-dried Dispersion formulation of ELQ-331; SEDDS: Self-Emulsifying Drug Delivery System of ELQ-331; CMC suspension: Carboxy methyl cellulose suspension; Cmax: Maximum observed plasma concentration; AUC last: Area under the plasma concentration-time curve up to the last measurable concentration. (Mean± SD; n=3). *Data was taken from previous study, ELQ-300 was administered orally in CMC suspension.